- Hitting a record high sale with business profits of KRW 106 billion and net profits of KRW 80.1 billion according to the accounting of 2022
- Not only stable positioning of Fexuclue but also achievement obtaining a permit of new medicine for Envlo
Daewoong Pharmaceutical (CEO Seng-ho Jeon, Chang-jae Lee) announced its 2022 annual report. On a standalone basis, sales increased from the previous year by 10.1% to KRW 1.16 trillion with business profits increased by 11.0% to KRW 106 billion and ne